Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 3737-3744, November 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rovera, G.
Right arrow Articles by Surrey, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rovera, G.
Right arrow Articles by Surrey, S.

Use of Resistant or Hypersensitive Variant Clones of Friend Cells in Analysis of Mode of Action of Inducers1

Giovanni Rovera2 and Stuart Surrey

The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104

Twenty-one variant clones of Friend erythroleukemia cell were isolated and characterized. Seventeen clones were resistant to induction of hemoglobin synthesis by one of eight drugs that have been reported to induce erythroid differentiation in clone 745. Four clones responded hypersensitively to dimethyl sulfoxide or hypoxanthine. The variant clones were treated with inducing drugs to determine whether patterns of cross-resistance or cross-sensitivity could be identified. On the basis of the results obtained, we divided the drugs into three classes. The first, arbitrarily named Class A, was the most common and included dimethyl sulfoxide, hypoxanthine, hexamethylene bisacetamide, 1-methyl-2-pyrrolidinone, tetramethylurea, pyridine N-oxide, N-methylacetamide, and 6-thioguanine. Every clone resistant to induction of hemoglobin synthesis by one of these drugs was found to be cross-resistant to induction by all other inducers of this class. Clones hypersensitive to dimethyl sulfoxide were also hypersensitive to hypoxanthine, and hypoxanthine-hypersensitive clones were hypersensitive to dimethyl sulfoxide. Clones that could not be induced to synthesize hemoglobin by butyric acid, a Class B inducer, could be induced to synthesize hemoglobin both by drugs of Class A and by hemin. Clones hypersensitive to dimethyl sulfoxide and hypoxanthine were not hypersensitive to induction by butyric acid. Butyric acid could induce synthesis of hemoglobin in clones resistant to induction by Class A inducers and in clones noninducible by hemin. Hemin, a Class C inducer, characteristically induced the synthesis of hemoglobin containing {alpha} and ß minor globin chains, but not ß major, both in wild-type cells and in some clones resistant to induction of hemoglobin synthesis by Class A and B inducers. Clones selected for survival in the presence of hemin were inducible by Class B inducers, but response to Class A inducers varied, and the composition of the globin chains induced differed from that of the wild-type cells.

1 Supported, in part, by USPHS Research Grants CA-19454, CA-10815, and CA-09171 from the National Cancer Institute and Grant RR-05540 from the Division of Research Resources.

2 Leukemia Society of America Scholar. To whom the requests for reprints should be addressed.

Received 5/22/78. Accepted 8/16/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.